| Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study MP Bogenschutz, AA Forcehimes, JA Pommy, CE Wilcox, PCR Barbosa, ... Journal of psychopharmacology 29 (3), 289-299, 2015 | 1150 | 2015 |
| Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum CM Wilson, AE Serrano, A Wasley, MP Bogenschutz, AH Shankar, ... Science 244 (4909), 1184-1186, 1989 | 598 | 1989 |
| MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ... Focus 21 (3), 315-328, 2023 | 589 | 2023 |
| Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial GE Woody, SA Poole, G Subramaniam, K Dugosh, M Bogenschutz, ... Jama 300 (17), 2003-2011, 2008 | 410 | 2008 |
| Classic hallucinogens in the treatment of addictions MP Bogenschutz, MW Johnson Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, 250-258, 2016 | 279 | 2016 |
| Sacred knowledge: Psychedelics and religious experiences WA Richards Columbia University Press, 2015 | 279 | 2015 |
| Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial MP Bogenschutz, S Ross, S Bhatt, T Baron, AA Forcehimes, E Laska, ... JAMA psychiatry 79 (10), 953-962, 2022 | 277 | 2022 |
| Olanzapine versus placebo in the treatment of borderline personality disorder MP Bogenschutz, HG Nurnberg Journal of Clinical Psychiatry 65 (1), 104-109, 2004 | 232 | 2004 |
| Development of a bibliography on religion, spirituality and addictions C Geppert, MP Bogenschutz, WR Miller Drug and alcohol review 26 (4), 389-395, 2007 | 208 | 2007 |
| Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance RJ Thoma, MA Monnig, PA Lysne, DA Ruhl, JA Pommy, M Bogenschutz, ... Alcoholism: Clinical and Experimental Research 35 (1), 39-46, 2011 | 192 | 2011 |
| Cognitive control in alcohol use disorder: deficits and clinical relevance CE Wilcox, CJ Dekonenko, AR Mayer, MP Bogenschutz, JA Turner Reviews in the Neurosciences 25 (1), 1-24, 2014 | 187 | 2014 |
| Health status of ayahuasca users PCR Barbosa, S Mizumoto, MP Bogenschutz, RJ Strassman Drug testing and analysis 4 (7-8), 601-609, 2012 | 157 | 2012 |
| Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial MP Bogenschutz, DM Donovan, RN Mandler, HI Perl, AA Forcehimes, ... JAMA internal medicine 174 (11), 1736-1745, 2014 | 130 | 2014 |
| Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses MP Bogenschutz, JM Pommy Drug testing and analysis 4 (7-8), 543-555, 2012 | 123 | 2012 |
| Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder MP Bogenschutz, SK Podrebarac, JH Duane, SS Amegadzie, TC Malone, ... Frontiers in pharmacology 9, 100, 2018 | 114 | 2018 |
| Psychological and neuropsychological assessment of regular hoasca users PCR Barbosa, RJ Strassman, DX Da Silveira, K Areco, R Hoy, J Pommy, ... Comprehensive psychiatry 71, 95-105, 2016 | 113 | 2016 |
| Therapeutic applications of classic hallucinogens MP Bogenschutz, S Ross Behavioral neurobiology of psychedelic drugs, 361-391, 2018 | 112 | 2018 |
| Pharmacotherapy for pregnant women with addictions WF Rayburn, MP Bogenschutz American Journal of Obstetrics and Gynecology 191 (6), 1885-1897, 2004 | 108 | 2004 |
| The psychedelic debriefing in alcohol dependence treatment: Illustrating key change phenomena through qualitative content analysis of clinical sessions EM Nielson, DG May, AA Forcehimes, MP Bogenschutz Frontiers in pharmacology 9, 325053, 2018 | 95 | 2018 |
| Spirituality and addiction. WR Miller, MP Bogenschutz Southern Medical Journal 100 (4), 433-437, 2007 | 95 | 2007 |
